PROGRESSION-FREE AND OVERALL SURVIVAL OF PATIENTS TREATED WITH PRESURGICAL SUNITINIB PRIOR TO CYTOREDUCTIVE NEPHRECTOMY (CN) IN CLEAR CELL SYNCHRONOUS METASTATIC RENAL CELL CARCINOMA (MRCC)

被引：0
|
作者：
Bex, Axel
Blank, Christian
Chowdhury, Simon
Nichol, David
Peters, John
Horenblas, Simon
O'Brien, Tim
Sarwar, Naveed
Haanen, John
Powles, Thomas
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.2096
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1768
引用
收藏
页码：E709 / E710
页数：2
相关论文
共 50 条
  • [1] SUNITINIB PRIOR TO CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC CLEAR CELL CARCINOMA
    Baradaran, Nima
    Drabkin, Harry
    Savage, Stephen
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E872 - E872
  • [2] Hand-Foot Syndrome and Progression-Free Survival in Patients Treated with Sunitinib for Metastatic Clear Cell Renal Cell Carcinoma
    Kucharz, Jakub
    Budnik, Monika
    Dumnicka, Paulina
    Pastuszczak, Maciej
    Kusnierz-Cabala, Beata
    Demkow, Tomasz
    Popko, Katarzyna
    Wiechno, Pawel
    [J]. ADVANCES IN MEDICINE AND MEDICAL RESEARCH, 2019, 1133 : 35 - 40
  • [3] Role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC).
    Ghatalia, Pooja
    Handorf, Elizabeth A.
    Deng, Mengying
    Zibelman, Matthew R.
    Abbosh, Philip
    Anari, Fern
    Greenberg, Richard E.
    Viterbo, Rosalia
    Chen, David
    Smaldone, Marc C.
    Kutikov, Alexander
    Geynisman, Daniel M.
    Uzzo, Robert Guy
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib (EORTC 30073 SURTIME)
    Bex, A.
    Mulders, P.
    Jewett, M. A. S.
    Wagstaff, J.
    van Velthoven, R.
    Pes, P. M. Laguna
    Wood, L.
    van Melick, H. H. E.
    Soetekouw, P.
    Lattouf, J. B.
    Powles, T.
    Boleti, E.
    de Jong, I-J.
    Rottey, S.
    Tombal, B.
    Marreaud, S.
    Collette, L.
    Collette, S.
    Blank, C. U.
    Haanen, J. B.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [5] Use of progression-free survival (PFS) to predict overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
    Halabi, S.
    Rini, B. I.
    Stadler, W. M.
    Small, E. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Association of primary tumor radiomic phenotypes and outcomes in patients (pts) with metastatic renal cell clear cell carcinoma (mRCC) treated with cytoreductive nephrectomy (CN).
    Cunha, Mateus Trinconi
    Stangler, Lucas
    Freire, Pedro
    Alves Pinto, Paulo Victor
    Almeida Coelho, Fernando Morbeck
    Viana, Publio
    Cordeiro, Mauricio
    Nahas, William Carlos
    Mota, Jose Mauricio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [7] The impact of insurance status on progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
    Castro, Daniela
    Tripathi, Nishita
    Sayegh, Nicolas
    Gebrael, Georges
    Li, Xiaochen
    Meza, Luis
    Zengin, Zeynep
    Chehrazi-Raffle, Alex
    Govindarajan, Ameish
    Dizman, Nazli
    Ebrahimi, Hedyeh
    Chawla, Neal
    Mercier, Benjamin
    Hsu, Joann
    Shi, Jessica
    Philip, Errol
    Bergerot, Cristiane
    Barragan-Carrillo, Regina
    Pal, Sumanta
    [J]. ONCOLOGIST, 2023, 28 : S5 - +
  • [8] The role of cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma and prognostic factors of overall survival
    Alvin, Low Wei Xiang
    [J]. BJU INTERNATIONAL, 2016, 118 : 28 - 28
  • [9] The role of cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma and prognostic factors for overall survival
    Low, W. X. A.
    Gu, T.
    Yuen, S. P. J.
    Lee, L. S.
    Toh, C. K.
    Kanesvaran, R.
    Tan, H. S.
    Huang, H. H.
    Lau, K. O. W.
    [J]. BJU INTERNATIONAL, 2015, 115 : 93 - 94
  • [10] The role of cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma and prognostic factors for overall survival
    Low, W. X. A.
    Gu, T.
    Lim, K. S. J.
    Yuen, S. P. J.
    Lee, L. S.
    Toh, C. K.
    Kanesvaran, R.
    Tan, H. S.
    Huang, H. H.
    Lau, K. O. W.
    [J]. BJU INTERNATIONAL, 2015, 115 : 8 - 8
12345